Home
>
National Drug Code (NDC)
>
Sulindac
Sulindac - 42291-751-18 - (Sulindac)
Drug Information of Sulindac
| Product NDC: | 42291-751 |
| Proprietary Name: | Sulindac |
| Non Proprietary Name: | Sulindac |
| Active Ingredient(s): | 200 mg/1 & nbsp; Sulindac |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Sulindac
| Product NDC: | 42291-751 |
| Labeler Name: | AvKARE, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA072711 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100125 |
Package Information of Sulindac
| Package NDC: | 42291-751-18 |
| Package Description: | 180 TABLET in 1 BOTTLE (42291-751-18) |
NDC Information of Sulindac
| NDC Code | 42291-751-18 |
| Proprietary Name | Sulindac |
| Package Description | 180 TABLET in 1 BOTTLE (42291-751-18) |
| Product NDC | 42291-751 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Sulindac |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100125 |
| Marketing Category Name | ANDA |
| Labeler Name | AvKARE, Inc. |
| Substance Name | SULINDAC |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
